RxDoctor Payments Data

Stephanie Strickland, MD

Family Medicine · Florence, SCNPI 1174886709

Payments from drug & device makers

$8,272in general payments, 2019–2025

Across 546 payments — averaging $15.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$1K
  • Lilly USA, LLC$836
  • AstraZeneca$627
  • Amgen$596
  • Pfizer$507
  • plus $2K from 33 others

What the payments were for

  • Food & beverage$8,15799%
  • Education$1141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,272 in reported general payments places this provider in the 90th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$130,000
Medicare patients
311
Services billed
1,766

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide264$360,816
MounjaroTirzepatide161$197,187
JardianceEmpagliflozin95$116,836
Humira(Cf) PenAdalimumab11$71,450
EliquisApixaban64$68,308
FarxigaDapagliflozin Propanediol57$65,560
VraylarCariprazine Hcl32$47,663
XareltoRivaroxaban36$46,593
Trelegy ElliptaFluticasone/Umeclidin/Vilanter61$46,588
TrulicityDulaglutide25$38,646
LinzessLinaclotide47$33,846
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog34$32,215
EntrestoSacubitril/Valsartan26$27,446
JanuviaSitagliptin Phosphate26$21,725
RybelsusSemaglutide16$20,256

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,030$381,072280 claims
Lilly USA, LLCMounjaro, Trulicity$836$235,833186 claims
Boehringer IngelheimJardiance, Synjardy Xr$134$136,901112 claims
AbbVieVraylar, Linzess, Ubrelvy$2,274$94,63791 claims
PfizerEliquis, Premarin$507$73,59683 claims
AstraZenecaFarxiga, Breztri Aerosphere$627$72,53968 claims
GSKTrelegy Ellipta, Anoro Ellipta$176$54,34575 claims
Johnson & JohnsonXarelto$38$46,59336 claims
MerckJanuvia, Belsomra$109$29,37540 claims
NovartisEntresto$169$27,44626 claims
Astellas Pharma US IncMyrbetriq$140$14,49017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Florence

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →